The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) AR: COVID-19 Emergency Response Project (P173767) LATIN AMERICA AND CARIBBEAN | Argentina | Health, Nutrition & Population Global Practice | IBRD/IDA | Investment Project Financing | FY 2020 | Seq No: 5 | ARCHIVED on 22-Jun-2022 | ISR50818 | Implementing Agencies: Argentine Republic, National Ministry of Health Key Dates Key Project Dates Bank Approval Date: 02-Apr-2020 Effectiveness Date: 07-May-2020 Planned Mid Term Review Date: 30-Sep-2022 Actual Mid-Term Review Date: 30-Mar-2022 Original Closing Date: 29-Apr-2022 Revised Closing Date: 30-Apr-2024 pdoTable Project Development Objectives Project Development Objective (from Project Appraisal Document) To strengthen preparedness and response efforts against the COVID-19 pandemic and national systems for public health preparedness in Argentina Has the Project Development Objective been changed since Board Approval of the Project Objective? No Components Table Name Emergency COVID-19 Response Efforts:(Cost $532.90 M) Implementation, Monitoring and Evaluation:(Cost $2.10 M) Overall Ratings Name Previous Rating Current Rating Progress towards achievement of PDO Satisfactory Satisfactory Overall Implementation Progress (IP) Satisfactory Satisfactory Overall Risk Rating High Substantial Implementation Status and Key Decisions The Argentina COVID-19 Emergency Response Project was approved by the WB Board of Directors on April 2, 2020 with the objective of strengthening the national health system for emergency preparedness and response to COVID-19 pandemic in an amount of US$ 35 million. This Project is part of a World Bank Multi-Phase Programmatic Approach to support countries affected by the COVID-19 pandemic. The Project was declared effective on May 7, 2020. As of May 31, 2021 all project activities were implemented and the Project’s funds are hundred percent disbursed. On September 30, the Board approved an Additional Financing Loan (AF) in an amount of US$ 500 million mainly to support the financing of vaccines . The AF Loan was declared effective on October 6, 2021. As of May 31, 2022 all project activities are under implementation and the Project is 99.6 percent disbursed. 6/22/2022 Page 1 of 8 The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) MPA Program Development Objective MPA PDO Table The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness MPA Table Multiphase Programmatic Approach (MPA) Status MPA Table Body As of June 15, 2022, 88 MPA-projects had been approved with a total commitment of US$4.3 billion. One operation (Guatemala) was cancelled in mid-September 2021, at the request of the Government. Six parent projects have been restructured to include vaccine-related procurement. Total disbursements as of June 15, 2022, amount to US$3.6 billion or 84% of overall commitments. This amount does not include disbursements under MPA-V operations which are reported together with AF-V operations. Sixty-seven (67) country projects or 77% of projects approved have reached 70-100% disbursement (reasons for >100% disbursements relate to fluctuations between the Euro and the SDR against the US$). Out of the 67 operations, 48 operations or 72% have disbursed over 90% of commitments. Of these, 30 operations are fully disbursed. There are thirteen (13) operations with closing dates by the end of FY22. Other 10 operations which had closing dates by the end of the FY have extended their closing dates. There are 12 operations with disbursements under 50%. Out of these 12 operations, one has not disbursed, and four have disbursed 30 percent or less. The projects are benefitting around 3.7 billion people or 50% of the global population. Of the 87 active projects: (i) 33 are in Africa – 12 in AFE and 21 in AFW; (ii) 12 in East Asia; (iii) 14 in Europe and Central Asia; (iv) 11 in Latin America and the Caribbean; (v) 8 in Middle East and North Africa; and (vi) 9 in South Asia. Eighty-six (86) or 99% of projects approved are disbursing. MNA has the highest percentage of disbursements, followed by SRA, EAP, ECA and LAC, AFE and AFW. Retroactive Financing represents 26% of commitments. Country teams for operations, which have been under implementation for twelve months or more by June 30, 2022, are preparing Mid-Term Review (MTR) ISRs to inform the Global MPA MTR, which will be prepared early next FY. Streamlined procedures, delegated approvals, coupled with flexible project design and intensified efforts across the Bank have contributed to the progress. Implementation is being guided by Bank teams working in parallel with other health related projects, including Additional Financing operations supporting vaccine procurement and deployment efforts. Implementation continues to face challenges as several countries are still under different levels of mobility restrictions. Bank staff are operating in a hybrid environment with some days at the office and others at home. Notwithstanding the challenges, the MPA is on track to achieve its PrDO, which is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. The significant level of disbursements attests to the strong implementation of the Bank' response thanks to the commitment of counterparts supported by Bank country teams. The Additional Financing (MPA AF-V) to the COVID-19 Strategic Preparedness and Response Program utilizing the Multiphase Programmatic Approach (“Global COVID-19 MPA”) was approved by the Board on October 13, 2021. The AF-V is significantly expanding Bank support to client countries for COVID-19 vaccination, with the aim to support vaccination of 1 billion people globally. The AF-V was approved with an envelope of US$12 billion ($6 billion from IDA and $6 billion from IBRD) in financing. On June 30, 2021, President Malpass announced the expansion of financing available for COVID-19 vaccine financing to $20 billion over the next 18 months, adding $8 billion to the previously announced $12 billion. This financing is critical to expand affordable and equitable financing for vaccine purchase and deployment. The AF-V is expected to enable vaccination for up to 750 million people, with potential surge capacity for an additional 250 million people in the poorest countries (depending on the delivered price of approved vaccines) while scaling support to strengthen immunization delivery, with design flexibility at the country level. The AF-V is a scale-up of planned vaccination activities anticipated and supported under the Global COVID-19 MPA and a key contribution to the WBG’s overall COVID-19 response. As of June 15, 2022, the Bank has approved 105 operations (including MPA-V operations) to support vaccine procurement and rollout in 77 countries amounting to $9.6 billion. The 105 operations approved, include 6 operations that involved restructuring of parent projects (Bhutan, Cameroon, North Macedonia, Philippines, and Pakistan) and in the case of Lebanon, restructuring of the Health Resilience Project. Of the 105 6/22/2022 Page 2 of 8 The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) approved operations: (i) 56 are in Africa – 26 in AFE and 30 in AFW; (ii) 9 in East Asia and the Pacific; (iii) 11 in Europe and Central Asia; (iv) 11 in Latin America and the Caribbean; (v) 9 in Middle East and North Africa; and (vi) 9 in South Asia. Fifty-three (53) projects are disbursing. Total disbursements as of June 15, 2022, under these projects amount to US$3.4 billion or 35% of overall commitments. Disbursements under MPA-V operations are included in this total while disbursements under the six restructured projects are counted under parent projects. Sixteen (16) operations have disbursed over 70% of their commitments. Out of the 16, seven have disbursed 90%. Retroactive Financing represents 44% of overall commitments. Thirteen (13) new operations are under various stages of processing. As with the MPA operations, streamlined procedures, delegated approval, coupled with flexible project design, and intensified efforts across the Bank have contributed to the rapid design and processing of the operations. Eighty-eight (88) loan/financing agreements have been signed. Also, eighty-six (86) loan/financing agreements have become effective; several others are expected to become effective in the coming weeks. Implementation of the AF- V operations, as with MPA operations is facing challenges as several countries are still under different levels of mobility restrictions and counterparts and Bank teams are operating in a hybrid environment with some days at the office and some at home. Countries are dealing with new waves of infections, as the Omicron variant continues to spread rapidly among populations. Risks Systematic Operations Risk-rating Tool Risk Category Rating at Approval Previous Rating Current Rating Political and Governance Moderate Moderate Moderate Macroeconomic High Substantial Substantial Sector Strategies and Policies Moderate Moderate Moderate Technical Design of Project or Program Substantial High Substantial Institutional Capacity for Implementation and Substantial Substantial Substantial Sustainability Fiduciary Moderate Substantial Moderate Environment and Social Moderate Substantial Substantial Stakeholders Low Low Low Other -- -- -- Overall Substantial High Substantial Results PDO Indicators by Objectives / Outcomes Support detection and response efforts in the fight against COVID-19 IN01121980 ►Percentage of suspected cases of COVID-19 reported and investigated per approved protocols (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target 6/22/2022 Page 3 of 8 The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) Value 0.00 91.34 94.70 90.00 Date 28-Feb-2020 02-Jun-2021 28-Feb-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122006 ►Percentage of diagnosed cases treated per approved protocols (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 99.85 100.00 90.00 Date 28-Feb-2020 02-Jun-2021 28-Feb-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122007 ►Percentage of acute healthcare facilities with increased isolation capacity (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 100.00 100.00 80.00 Date 28-Feb-2020 28-May-2021 28-Feb-2022 31-Dec-2021 IN01122008 ►Percentage of population vaccinated, which is included in the priority population targets, as defined in the NSVP for the Introduction of the Vaccine against COVID-19 (disaggregated by sex) (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 31.80 32.70 Date 30-Jun-2021 30-Jun-2021 31-Mar-2022 29-Dec-2023 IN01122009 ►Percentage of female population vaccinated, which is included in the priority population targets, as defined in the NSVP for the Introduction of the Vaccine against COVID-19 (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 32.80 32.70 Date 30-Jun-2021 30-Jun-2021 31-Mar-2022 29-Dec-2023 End- Project target has been achieved. Comments: Intermediate Results Indicators by Components Emergency COVID-19 Response Efforts IN01122010 ►Number of laboratories conducting COVID-19 sample testing (Number, Custom) 6/22/2022 Page 4 of 8 The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) Baseline Actual (Previous) Actual (Current) End Target Value 1.00 34.00 35.00 24.00 Date 28-Feb-2020 28-May-2021 28-Feb-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122011 ►Percentage of public hospitals with Intensive Care Units strengthened (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 72.50 72.49 90.00 Date 28-Feb-2020 28-May-2021 31-Mar-2022 31-Dec-2021 IN01122012 ►Percentage of public hospitals with Intensive Care Units that received training according approved protocols (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 87.00 87.00 80.00 Date 28-Feb-2020 28-May-2021 31-Dec-2021 29-Dec-2023 End- Project Target has been achieved Comments: IN01122013 ►Percentage of participating hospitals with personal protective equipment and infection control products and supplies, provided (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 74.60 74.67 90.00 Date 28-Feb-2020 28-May-2021 31-Mar-2022 31-Dec-2021 IN01122014 ►AR COVID-19 Fatality Rate (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 2.10 1.40 2.50 Date 28-Feb-2020 01-Jun-2021 28-Feb-2022 29-Dec-2023 IN01122015 ►Provincial Emergency Committees with multisectoral participation, including civil society organizations, created and operational” (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 70.80 70.83 70.00 Date 19-Mar-2020 28-May-2021 31-Dec-2021 29-Dec-2023 Comments: Percentage of provinces that implement an Emergency Committees ( COE) since the beginning of the pandemic, according to the guidelines of the Ministry of Health (MoH) with the participation of Civil Society Organizations (SCO) and/or private health sector representatives. 6/22/2022 Page 5 of 8 The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) End- Project target has been achieved. IN01122016 ►Number of doses of COVID-19 vaccine procured with Project funding (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 30,026,331.00 30,000,000.00 Date 30-Jun-2021 30-Jun-2021 31-Mar-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122017 ►Health staff trained in COVID-19 vaccination process according to protocols approved by the NMOH (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 5,000.00 5,000.00 7,336.00 10,000.00 Date 30-Jun-2021 30-Jun-2021 28-Feb-2022 29-Dec-2023 IN01122018 ►Percentage of provinces with updated vaccination plans to implement the NSVP against COVID-19 (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 100.00 90.00 Date 30-Jun-2021 30-Jun-2021 31-Dec-2021 29-Dec-2023 End- Project target has been achieved. Comments: IN01122019 ►Updated health management and information system to deploy a Pharmacovigilance strategy of AEFIs for COVID-19 vaccination with new guidelines according the NSVP and NMOH technical guidelines (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No No Yes Yes Date 30-Jun-2021 30-Jun-2021 31-Mar-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122020 ►New Communication strategies developed and disseminated in support of the NSVP (Yes/No, Custom) Baseline Actual (Previous) Actual (Current) End Target Value No No Yes Yes Date 30-Jun-2021 30-Jun-2021 31-Mar-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122021 6/22/2022 Page 6 of 8 The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) ►Share of women vaccinated against COVID-19 with at least one dose in the Northeastern region, in line with national average (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 51.00 55.00 73.00 59.00 Date 03-Aug-2021 23-Aug-2021 31-Mar-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122022 ►Share of women trained as vaccinators (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 50.00 50.00 79.00 60.00 Date 30-Jun-2021 30-Jun-2021 31-Dec-2021 29-Dec-2023 End- Project target has been achieved. Comments: IN01122023 ►Share of female workers responsible for COVID-19 vaccination campaigns in Expanded Programs on Immunization (EPI) throughout the country (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 45.00 45.00 79.00 50.00 Date 30-Jun-2021 30-Jun-2021 28-Feb-2022 29-Dec-2023 End- Project target has been achieved. Comments: IN01122024 ►Population fully vaccinated included in the priority population targets defined in the NSVP and NMOH technical guidelines (total and disaggregated by sex) (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 14.00 14.00 80.00 70.00 Date 30-Jun-2021 30-Jun-2021 31-Mar-2022 29-Dec-2023 End- Project target has been achieved. Comments: Performance-Based Conditions Data on Financial Performance Disbursements (by loan) Project Loan/Credit/TF Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed 6/22/2022 Page 7 of 8 The World Bank Implementation Status & Results Report AR: COVID-19 Emergency Response Project (P173767) P173767 IBRD-90830 Closed USD 35.00 35.00 0.00 35.00 0.00 100% P173767 IBRD-92920 Effective USD 500.00 500.00 0.00 498.00 2.00 100% Key Dates (by loan) Project Loan/Credit/TF Status Approval Date Signing Date Effectiveness Date Orig. Closing Date Rev. Closing Date P173767 IBRD-90830 Closed 02-Apr-2020 05-May-2020 07-May-2020 29-Apr-2022 29-Apr-2022 P173767 IBRD-92920 Effective 30-Sep-2021 04-Oct-2021 06-Oct-2021 30-Apr-2024 30-Apr-2024 Cumulative Disbursements Restructuring History There has been no restructuring to date. Related Project(s) P177246-Additional Financing for the Argentina: COVID-19 Emergency Response Project 6/22/2022 Page 8 of 8